Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Tate

Showing results (161-170 of 224) with videos related to

Pageof 23
Sort By:
Journal of Thrombosis and Haemostasis : JTH|September 17, 2011
Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopeniaB Psaila, J B Bussel, A L Frelinger, et al.
Journal of Neuro-Oncology|January 28, 2026
A phase 2, open label, clinical trial of pre-surgical and adjuvant treatment of recurrent glioblastoma with tremelimumab and durvalumab alone and in combinationKaran S Dixit, Priya Kumthekar, Rimas V Lukas, et al.
Neurosurgery Practice|February 17, 2025
Initial Patient Satisfaction With Telemedicine in Neurosurgery Outpatient Clinic During the Early COVID-19 PandemicOlivia A Kozel, Archit B Baskaran, Anusha Manjunath, et al.
Clinical Neurology and Neurosurgery|October 25, 2022
Low-molecular-weight Heparin (enoxaparin) versus unfractionated heparin for venous thromboembolism prophylaxis in patients undergoing craniotomyViswajit Kandula, Parth V Shah, Vineeth M Thirunavu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2014
Semi-mechanistic pharmacokinetic/pharmacodynamic modeling of the antitumor activity of LY2835219, a new cyclin-dependent kinase 4/6 inhibitor, in mice bearing human tumor xenograftsSonya C Tate, Shufen Cai, Rose T Ajamie, et al.
Urogynecology (Philadelphia, Pa.)|September 30, 2025
Sex Disparities in Normal Pressure Hydrocephalus Diagnosis and Urinary OutcomesNishanth S Sadagopan, Rishi Jain, Rahul K Chaliparambil, et al.
The Clinical Neuropsychologist|February 15, 2024
Neurocognitive change over the course of a multiday external lumbar drain trial in patients with suspected normal pressure hydrocephalusMichael Brook, James Reilly, Alexander Korutz, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 21, 2012
Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte dataHannah M Jones, Hugh A Barton, Yurong Lai, et al.
Neuro-Oncology Practice|February 7, 2025
Clinical outcomes for pleomorphic xanthoastrocytoma patientsJared J Sullivan, James P Chandler, Maciej S Lesniak, et al.
Cancers|November 13, 2025
Surgical Treatment of Brain Tumor-Related Epilepsy: Current and Emerging StrategiesBobak F Khalili, Michael R Chojnacki, Karan Dixit, et al.
Pageof 23

Showing results (161-170 of 224) with videos related to

Sort By:
Pageof 23
Journal of Thrombosis and Haemostasis : JTH|September 17, 2011
Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopeniaB Psaila, J B Bussel, A L Frelinger, et al.
Journal of Neuro-Oncology|January 28, 2026
A phase 2, open label, clinical trial of pre-surgical and adjuvant treatment of recurrent glioblastoma with tremelimumab and durvalumab alone and in combinationKaran S Dixit, Priya Kumthekar, Rimas V Lukas, et al.
Neurosurgery Practice|February 17, 2025
Initial Patient Satisfaction With Telemedicine in Neurosurgery Outpatient Clinic During the Early COVID-19 PandemicOlivia A Kozel, Archit B Baskaran, Anusha Manjunath, et al.
Clinical Neurology and Neurosurgery|October 25, 2022
Low-molecular-weight Heparin (enoxaparin) versus unfractionated heparin for venous thromboembolism prophylaxis in patients undergoing craniotomyViswajit Kandula, Parth V Shah, Vineeth M Thirunavu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2014
Semi-mechanistic pharmacokinetic/pharmacodynamic modeling of the antitumor activity of LY2835219, a new cyclin-dependent kinase 4/6 inhibitor, in mice bearing human tumor xenograftsSonya C Tate, Shufen Cai, Rose T Ajamie, et al.
Urogynecology (Philadelphia, Pa.)|September 30, 2025
Sex Disparities in Normal Pressure Hydrocephalus Diagnosis and Urinary OutcomesNishanth S Sadagopan, Rishi Jain, Rahul K Chaliparambil, et al.
The Clinical Neuropsychologist|February 15, 2024
Neurocognitive change over the course of a multiday external lumbar drain trial in patients with suspected normal pressure hydrocephalusMichael Brook, James Reilly, Alexander Korutz, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 21, 2012
Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte dataHannah M Jones, Hugh A Barton, Yurong Lai, et al.
Neuro-Oncology Practice|February 7, 2025
Clinical outcomes for pleomorphic xanthoastrocytoma patientsJared J Sullivan, James P Chandler, Maciej S Lesniak, et al.
Cancers|November 13, 2025
Surgical Treatment of Brain Tumor-Related Epilepsy: Current and Emerging StrategiesBobak F Khalili, Michael R Chojnacki, Karan Dixit, et al.
Pageof 23